Cargando…
Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
INTRODUCTION: Parenteral Nutrition (PN) can lead to intestinal failure associated liver disease (IFALD). There are no human studies to date studying specifically the benefits of light-protection on neonatal IFALD. Recently, the European Medicines Agency and the American Society for Parenteral and En...
Autores principales: | Clauss, Christie, Tack, Valentyna, Macchiarulo, Maria, Akerman, Meredith, El-Chaar, Gladys, Hanna, Nazeeh, Tiozzo, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381878/ https://www.ncbi.nlm.nih.gov/pubmed/35989991 http://dx.doi.org/10.3389/fped.2022.900068 |
Ejemplares similares
-
Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants
por: Clauss, Christie, et al.
Publicado: (2020) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022) -
The Next Frontier of Prematurity: Predicting Respiratory Morbidity During the First Two Years of Life in Extremely Premature Babies
por: Weinstock, Jered, et al.
Publicado: (2022) -
Dexamethasone may affect the occurrence of parenteral nutrition-associated cholestasis in preterm neonates
por: Jiang, Saizhi, et al.
Publicado: (2022) -
Evaluation of the Mortality and Morbidity of Premature Infants During a Five-Year Period in the Neonatal Intensive Care Unit
por: Çelik, Elif, et al.
Publicado: (2021)